6 months after COVID-19 hit, one trend has emerged as a dominant theme: making virtual clinical trials a reality. Catch up on the recent survey data.
If you’re going to start a clinical trial in the post-COVID area, a virtual investigator meeting needs to be in your plans. Here’s how to do it.
Interview: Start-Up Phase is a Prime Target for Virtual Activities in Clinical Trials, So Let’s Adapt
Before 2020 “virtual clinical trials” was just a buzzword. Now we’re forced to adapt. But what challenges – and opportunities – are ahead?
As COVID-19 continues to impact us, principle investigator meetings are off the table. Or are they? Yes, you can pull off an effective, virtual investigator meeting for your clinical trial. Here’s how to make sure you do.
Interview: Adopting Consumer Tech in Clinical Trials Will Pave the Way for Hybrid and Virtual Trials
Can we make virtual trials a reality? In order to succeed, we need to start now with adopting technologies more broadly. Wearables, sensors, and other devices promise to pave the way for a more virtual future and have an immediate impact on trials today, particularly in rare disease. Read our interview with Kemi Olugemo, M.D., Head of Neurology at Akcea Therapeutics for her expert predictions and advice.
Need to virtualize everything you can in your clinical trial? Check out these 7 tips to transform the content you deliver to investigators, sites, personnel, and trial team members.